{"meta":{"query_hash":"137bacb60294","filters":{"venue":"05.01 - Airway pharmacology and treatment"},"cohort_total":11,"direct_labels_cover":0,"predictions_cover":11,"exported":11,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/137bacb60294","api":"https://metacan.xera.ac/api/v1/cohort?venue=05.01+-+Airway+pharmacology+and+treatment"},"results":[{"id":"W4312280085","doi":"10.1183/13993003.congress-2022.2256","title":"Relation between reduction in fractional exhaled nitric oxide and efficacy in asthma patients treated with dupilumab","year":2022,"lang":"en","type":"article","venue":"05.01 - Airway pharmacology and treatment","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Dupilumab; Exhaled nitric oxide; Medicine; Placebo; Exacerbation; Asthma; Internal medicine; Bronchodilator; Gastroenterology; Lung function; Lung; Pathology; Spirometry","score_opus":0.01349194521835311,"score_gpt":0.2804429612581072,"score_spread":0.2669510160397541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312280085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980021,0.001111661,0.000046908306,0.00007233982,0.000011428695,0.000009323979,0.00023879664,0.000005186152,0.00050226063],"genre_scores_gemma":[0.9994709,0.00008614341,0.000043796008,0.000039949802,0.000014384439,0.0000067608444,0.00021698272,9.3912263e-7,0.00012005859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995654,0.00013251689,0.00004948433,0.00009820921,0.00008973778,0.00006462867],"domain_scores_gemma":[0.99791783,0.0008250478,0.0006684746,0.00008066814,0.0001830906,0.000324902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009089858,0.00017042905,0.00047283148,0.00026410713,0.00017116647,0.0003693575,0.00019690732,0.0005613329,0.0012009655],"category_scores_gemma":[0.0019412449,0.00011093652,0.00043514976,0.00021708733,0.00011749539,0.00022542407,0.00012231179,0.00066706905,0.00015149413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01199823,0.0003472238,0.9707003,0.000080888516,0.0004415643,0.00012830997,0.00006614262,0.0003866958,0.0024887703,0.00003497451,0.00057532405,0.012751481],"study_design_scores_gemma":[0.00015657448,0.0020894024,0.9958643,0.000015242038,0.00014509786,0.00022889183,0.000044438857,0.00081233366,0.00025978385,0.000019970194,0.00035637186,0.000007725748],"about_ca_topic_score_codex":0.0010079162,"about_ca_topic_score_gemma":0.0013595264,"teacher_disagreement_score":0.0012009655,"about_ca_system_score_codex":0.0002932825,"about_ca_system_score_gemma":0.00014455372,"threshold_uncertainty_score":0.004807234},"labels":[],"label_agreement":null},{"id":"W4312294278","doi":"10.1183/13993003.congress-2022.1020","title":"Reduction in work and activity impairment within 6 months of benralizumab initiation in Canadians with severe eosinophilic asthma","year":2022,"lang":"en","type":"article","venue":"05.01 - Airway pharmacology and treatment","topic":"Pediatric health and respiratory diseases","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Impact; University of Regina; University of Calgary; Vitalité Health Network; McMaster University; Barrie Urology Group; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; AstraZeneca (Canada); University of Alberta; University of Saskatchewan","funders":"","keywords":"Benralizumab; Medicine; Absenteeism; Asthma; Internal medicine; Physical therapy; Eosinophil; Mepolizumab; Psychology","score_opus":0.025383369555399625,"score_gpt":0.347704283367291,"score_spread":0.3223209138118914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312294278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98617804,0.002740487,0.00008602925,0.00079310377,0.000036117202,0.00006319645,0.006717537,0.000011050468,0.0033745153],"genre_scores_gemma":[0.99554896,0.0008469245,0.00015759435,0.0002131424,0.000020017062,0.000021446744,0.0026563937,0.000002901109,0.0005326451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992306,0.000048990387,0.00004667087,0.000112922244,0.00027907296,0.00028166705],"domain_scores_gemma":[0.9985789,0.0000527617,0.00038998705,0.0000305051,0.00059454556,0.0003532903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066037447,0.0003272927,0.00044556314,0.0006754552,0.001991941,0.00064591423,0.00074718054,0.0004897299,0.0021806487],"category_scores_gemma":[0.0015779787,0.00018935309,0.0007027186,0.0022340976,0.00039801042,0.00027865326,0.0004387372,0.000798645,0.0002130309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028862857,0.000060244023,0.9899625,0.0000963043,0.000060853967,0.000084936306,0.00024525015,0.00006637526,0.00019395871,0.000029602415,0.0017605408,0.0071508065],"study_design_scores_gemma":[0.00001802916,0.00004292013,0.9987124,0.000035925837,0.000032953325,0.000065012544,0.00024350602,0.00008460455,0.000033033713,0.0000080431555,0.00071679114,0.000006675677],"about_ca_topic_score_codex":0.9739199,"about_ca_topic_score_gemma":0.9809365,"teacher_disagreement_score":0.026080072,"about_ca_system_score_codex":0.012167235,"about_ca_system_score_gemma":0.013995834,"threshold_uncertainty_score":0.08827984},"labels":[],"label_agreement":null},{"id":"W4312468892","doi":"10.1183/13993003.congress-2022.801","title":"Characteristics of Participants with Refractory Chronic Cough Enrolled in A Phase 2b Trial of BLU-5937","year":2022,"lang":"en","type":"article","venue":"05.01 - Airway pharmacology and treatment","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bellus Health (Canada)","funders":"","keywords":"Demographics; Placebo; Medicine; Refractory (planetary science); Population; Randomized controlled trial; Internal medicine; Exploratory analysis; Demography","score_opus":0.046963237389640484,"score_gpt":0.37643598631833897,"score_spread":0.3294727489286985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312468892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768148,0.0029243522,0.0011143526,0.0006533219,0.00012012389,0.0016751395,0.011757366,0.000034831457,0.004905661],"genre_scores_gemma":[0.98423314,0.00067062135,0.0007558336,0.0014277598,0.00011241901,0.0039399364,0.006623904,0.000017779146,0.0022186802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990534,0.00024886255,0.00014691828,0.00023095794,0.00017451636,0.00014529764],"domain_scores_gemma":[0.9988009,0.00026901913,0.00045274122,0.00009845524,0.00015376841,0.00022524812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019814926,0.0003331679,0.00068156427,0.00043986976,0.00063214713,0.00043109673,0.00028948692,0.0007571623,0.005120794],"category_scores_gemma":[0.0030192824,0.0002417497,0.00081155926,0.0005906851,0.00026809226,0.0007361462,0.00029601523,0.00075948454,0.0008113485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.074264094,0.0039247917,0.84826267,0.0010067215,0.0015766295,0.00087006576,0.0006958462,0.00055172574,0.008239602,0.00051862124,0.016132383,0.043956876],"study_design_scores_gemma":[0.007458964,0.01889108,0.95304537,0.00025715685,0.000718739,0.0015969295,0.00079970696,0.0009663024,0.0006511602,0.0008717094,0.014667471,0.00007532],"about_ca_topic_score_codex":0.001113482,"about_ca_topic_score_gemma":0.0017124334,"teacher_disagreement_score":0.005120794,"about_ca_system_score_codex":0.000295466,"about_ca_system_score_gemma":0.00069266907,"threshold_uncertainty_score":0.017130733},"labels":[],"label_agreement":null},{"id":"W4312533237","doi":"10.1183/13993003.congress-2022.3394","title":"Association between sub-optimal medication adherence and risk of COPD diagnosis in patients with physician-diagnosed asthma: A propensity score-based analysis","year":2022,"lang":"en","type":"article","venue":"05.01 - Airway pharmacology and treatment","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Asthma; COPD; Hazard ratio; Propensity score matching; Internal medicine; Confidence interval; Cohort; Proportional hazards model; Incidence (geometry); Population; Cohort study; Marginal structural model; Relative risk","score_opus":0.024819562596541334,"score_gpt":0.2810162613251445,"score_spread":0.2561966987286032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312533237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974031,0.00035961368,0.0013605366,0.000081877784,0.000015204887,0.000036448022,0.00045713998,0.000012116532,0.00027399417],"genre_scores_gemma":[0.9990709,0.000060590573,0.00036754945,0.000022733257,0.000011956368,0.000020143969,0.00035885736,0.0000030808103,0.00008417898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798346,0.0010309828,0.00021507381,0.00037148665,0.00026088217,0.0001380341],"domain_scores_gemma":[0.99531174,0.0014278623,0.0017507763,0.0008481984,0.0003453014,0.0003161046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038469378,0.00029766743,0.0006038791,0.001350897,0.0004515787,0.000891757,0.0005363636,0.0006371642,0.0018593231],"category_scores_gemma":[0.0073748683,0.00035207794,0.0018728427,0.002030902,0.00032993846,0.00047343958,0.00061452435,0.000773672,0.00020312036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004891381,0.00005014674,0.99664354,0.000014845615,0.00080411043,0.000027857572,0.00003521262,0.00027904278,0.00008486892,0.00007188513,0.00017367552,0.0013257331],"study_design_scores_gemma":[0.00008564823,0.00027054304,0.9911843,0.000011999798,0.0006088125,0.0001453779,0.00007244026,0.0070225783,0.000062341496,0.00019039909,0.0003337697,0.000011718536],"about_ca_topic_score_codex":0.004884214,"about_ca_topic_score_gemma":0.003304391,"teacher_disagreement_score":0.004884214,"about_ca_system_score_codex":0.00034692802,"about_ca_system_score_gemma":0.0004956153,"threshold_uncertainty_score":0.020344853},"labels":[],"label_agreement":null},{"id":"W4312603183","doi":"10.1183/13993003.congress-2022.1025","title":"Sustained improvement of asthma control over 6 months of benralizumab treatment in Canadians with severe asthma","year":2022,"lang":"en","type":"article","venue":"05.01 - Airway pharmacology and treatment","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; University of Alberta; Vitalité Health Network; McMaster University; Barrie Urology Group; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Impact; University of Regina; University of Calgary; AstraZeneca (Canada)","funders":"","keywords":"Benralizumab; Medicine; Minimal clinically important difference; Asthma; Interim analysis; Internal medicine; Cohort; Randomization; Randomized controlled trial; Eosinophil; Mepolizumab","score_opus":0.00611052222245248,"score_gpt":0.25817004151280665,"score_spread":0.2520595192903542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312603183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987153,0.002836065,0.00014048292,0.0006389921,0.0000397533,0.00011994295,0.005593914,0.00001608682,0.0034616883],"genre_scores_gemma":[0.9959943,0.0006239356,0.00022835002,0.00023848719,0.000018399263,0.00003249948,0.0023316469,0.00000392823,0.0005285016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873406,0.00013100544,0.00006890491,0.00019103107,0.00050132815,0.0003735765],"domain_scores_gemma":[0.9982206,0.00010043221,0.00042905522,0.00005994199,0.0007973979,0.00039245124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012123655,0.00031867088,0.0005706373,0.00050392793,0.002070734,0.00067356304,0.0007388931,0.00043581394,0.0018764863],"category_scores_gemma":[0.0025361967,0.00022405248,0.00085078826,0.0017301011,0.0005062845,0.0002760576,0.00048295883,0.0006952125,0.0001982927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002258415,0.00017880749,0.97134036,0.0002221652,0.0003355852,0.00011114909,0.0004056906,0.0001882333,0.0005112624,0.00011003336,0.0030856382,0.02125269],"study_design_scores_gemma":[0.00017033411,0.00025836602,0.99730575,0.000048876762,0.00015919731,0.000079143625,0.0002499202,0.0002192237,0.00008671519,0.000030216204,0.0013759214,0.000016359318],"about_ca_topic_score_codex":0.9715917,"about_ca_topic_score_gemma":0.98018485,"teacher_disagreement_score":0.028408289,"about_ca_system_score_codex":0.018378178,"about_ca_system_score_gemma":0.022202203,"threshold_uncertainty_score":0.13334364},"labels":[],"label_agreement":null},{"id":"W4312732011","doi":"10.1183/13993003.congress-2022.3409","title":"Association of Short-Acting-β-2 Agonist (SABA) Overuse and Risk of COPD among Adult Asthma Patients","year":2022,"lang":"en","type":"article","venue":"05.01 - Airway pharmacology and treatment","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Asthma; COPD; Association (psychology); Agonist; Medicine; B2 receptor; Internal medicine; Psychology; Receptor","score_opus":0.011916154607704009,"score_gpt":0.2935067825989839,"score_spread":0.2815906279912799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312732011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977264,0.00077752175,0.000052224965,0.00014157036,0.000011092001,0.0000075146268,0.00085665926,0.0000049322184,0.00042212618],"genre_scores_gemma":[0.9991116,0.00019209711,0.00005190321,0.000041033574,0.00002078798,0.0000062520494,0.00045881103,0.0000013025016,0.00011608855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935466,0.00013560057,0.00009525781,0.00014601384,0.00016134046,0.00010714292],"domain_scores_gemma":[0.9965681,0.00058810884,0.0018550946,0.0002330404,0.00033423034,0.00042155728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076410157,0.00022235785,0.00031402483,0.0006392475,0.00036445697,0.0007040067,0.00037429415,0.0005763966,0.0016458867],"category_scores_gemma":[0.0032744997,0.00029740616,0.00056403916,0.0010678413,0.00019616674,0.0003595167,0.00036602365,0.0009128368,0.00016867447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043811237,0.000013209317,0.9994905,0.000005672789,0.000033105418,0.000013205236,0.0000099740455,0.000011373923,0.00002790642,0.0000037493523,0.0000635305,0.0002839487],"study_design_scores_gemma":[0.000004173689,0.000030112786,0.999569,0.000005697775,0.000027239577,0.00008327365,0.000035819347,0.00013748398,0.000013316467,0.000006791054,0.00008552448,0.0000015669389],"about_ca_topic_score_codex":0.024136744,"about_ca_topic_score_gemma":0.024251316,"teacher_disagreement_score":0.024136744,"about_ca_system_score_codex":0.00045813076,"about_ca_system_score_gemma":0.0005983576,"threshold_uncertainty_score":0.047992527},"labels":[],"label_agreement":null},{"id":"W4312742691","doi":"10.1183/13993003.congress-2022.2074","title":"Dose delivery characteristics and lung deposition of indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF) and IND/MF via Breezhaler® device: An Alberta Idealised Throat (AIT) evaluation","year":2022,"lang":"en","type":"article","venue":"05.01 - Airway pharmacology and treatment","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Indacaterol; Dry-powder inhaler; Deposition (geology); Mometasone furoate; Inhalation; Materials science; Inhaler; Lung; Drug delivery; Medicine; Biomedical engineering; Lung function; Asthma; Anesthesia; Nanotechnology; Surgery; Internal medicine","score_opus":0.024376540366950267,"score_gpt":0.3141859573800662,"score_spread":0.28980941701311597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312742691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975948,0.0007747211,0.0009837693,0.00002383808,0.000006014767,0.000027234355,0.00017804748,0.000024570167,0.000386833],"genre_scores_gemma":[0.9965546,0.0007126007,0.0016533053,0.000035251138,0.0000052683044,0.000028368717,0.00019091237,0.000012705874,0.0008070524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987566,0.000022847238,0.000007706521,0.000024085095,0.000053267475,0.000016383652],"domain_scores_gemma":[0.9998913,0.00003240267,0.000036737554,0.000007094378,0.000021668255,0.000010791545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022813855,0.00015848519,0.00012765518,0.00016486694,0.00007293004,0.00018784919,0.00015389617,0.00027650277,0.0008997044],"category_scores_gemma":[0.00021878,0.00009797675,0.00022912845,0.00010863057,0.00011753156,0.00018732208,0.000090721645,0.00020393114,0.00018674997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010259447,0.00015551083,0.0024786359,0.000108695014,0.000020215051,0.00010784152,0.000053370055,0.0009830528,0.987415,0.000035293924,0.0001401535,0.007476308],"study_design_scores_gemma":[0.00004792806,0.0068801544,0.026531115,0.0000080171485,0.00006621861,0.0004079647,0.00008162094,0.0068493686,0.9577212,0.000021244878,0.0013682423,0.000016947119],"about_ca_topic_score_codex":0.0012496201,"about_ca_topic_score_gemma":0.0009529791,"teacher_disagreement_score":0.0012496201,"about_ca_system_score_codex":0.00028727774,"about_ca_system_score_gemma":0.00012186997,"threshold_uncertainty_score":0.0030097961},"labels":[],"label_agreement":null},{"id":"W4312847172","doi":"10.1183/13993003.congress-2022.3994","title":"Benralizumab attenuates blood and airway eosinophilia in severe asthmatics with inadequate response to anti-IL-5 neutralizing antibodies","year":2022,"lang":"en","type":"article","venue":"05.01 - Airway pharmacology and treatment","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Benralizumab; Medicine; Eosinophilia; Sputum; Mepolizumab; Immunology; Asthma; Placebo; Exhaled nitric oxide; Prednisone; Internal medicine; Gastroenterology; Eosinophil; Spirometry; Tuberculosis; Pathology","score_opus":0.014956865815718874,"score_gpt":0.2855800193315072,"score_spread":0.2706231535157883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312847172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987741,0.0007456433,0.00008186564,0.000057485417,0.000021086982,0.00006824394,0.000029684372,0.000011566753,0.00021021778],"genre_scores_gemma":[0.9988513,0.00028481553,0.00022731826,0.00014657147,0.00003952807,0.000056897676,0.00011561819,0.0000029595599,0.00027495596],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99975616,0.000092579845,0.000024697832,0.000025760866,0.000034018423,0.0000668997],"domain_scores_gemma":[0.9996698,0.00006618221,0.000099222874,0.000021934626,0.000022816866,0.0001200763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008374829,0.00053037354,0.00085442746,0.00013804607,0.00016603056,0.0002937238,0.00023943401,0.00038251246,0.0010135623],"category_scores_gemma":[0.00052724517,0.00021685625,0.00031419523,0.00008085029,0.00027677257,0.00018748666,0.0001686243,0.00084104965,0.00022181087],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20077677,0.027385255,0.063948154,0.0009294959,0.0006035323,0.0008438197,0.00028909685,0.0010877225,0.5307718,0.00011147803,0.0019793722,0.17127353],"study_design_scores_gemma":[0.05913239,0.5074067,0.380549,0.0001234898,0.0005134742,0.0021134818,0.00022100388,0.0023401363,0.04315721,0.00008760924,0.004325839,0.00002964391],"about_ca_topic_score_codex":0.0004575612,"about_ca_topic_score_gemma":0.0011205839,"teacher_disagreement_score":0.0010135623,"about_ca_system_score_codex":0.00021033744,"about_ca_system_score_gemma":0.0002987341,"threshold_uncertainty_score":0.004429102},"labels":[],"label_agreement":null},{"id":"W4312902543","doi":"10.1183/13993003.congress-2022.807","title":"Efficacy in SOOTHE, A Phase 2b Trial of BLU-5937 In Refractory Chronic Cough, Was Not Dependant of Taste Disturbance Adverse Events","year":2022,"lang":"en","type":"article","venue":"05.01 - Airway pharmacology and treatment","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bellus Health (Canada)","funders":"","keywords":"Discontinuation; Placebo; Medicine; Adverse effect; Refractory (planetary science); Chronic cough; Internal medicine; Population; Confounding; Incidence (geometry); Biology; Pathology","score_opus":0.032541369635219745,"score_gpt":0.36674652947092595,"score_spread":0.3342051598357062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312902543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98289007,0.0031931803,0.0010470134,0.0010438007,0.00025134996,0.0023845239,0.0023090383,0.00023591258,0.0066450946],"genre_scores_gemma":[0.98947597,0.0012614932,0.0012823349,0.0014372088,0.00014174587,0.0011704131,0.0020041587,0.000050629907,0.0031759955],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99965394,0.00013626754,0.00002766593,0.00006045642,0.000054203017,0.0000674617],"domain_scores_gemma":[0.99956626,0.00012812289,0.000116842726,0.0000407653,0.000051838313,0.00009611165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001044484,0.00045575533,0.0009203075,0.00022890922,0.00032283145,0.0005224307,0.00034652837,0.0010812625,0.009124732],"category_scores_gemma":[0.0014387703,0.00016343962,0.00089446007,0.00015163589,0.00044195596,0.0006116967,0.00021288349,0.0013420051,0.0008562563],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62140614,0.013451511,0.0067318385,0.004883772,0.001556441,0.00041816878,0.00044512117,0.0013291404,0.11837017,0.0015431361,0.013939089,0.21592548],"study_design_scores_gemma":[0.57640237,0.33697528,0.03843591,0.000374324,0.0016527774,0.0007286862,0.00020671387,0.0022852996,0.02156411,0.0007009646,0.020590141,0.000083374944],"about_ca_topic_score_codex":0.0005704364,"about_ca_topic_score_gemma":0.0024628465,"teacher_disagreement_score":0.009124732,"about_ca_system_score_codex":0.0003886179,"about_ca_system_score_gemma":0.0009018987,"threshold_uncertainty_score":0.030525267},"labels":[],"label_agreement":null},{"id":"W4313048206","doi":"10.1183/13993003.congress-2022.950","title":"The Effect of Inhaled Salbutamol on Mannitol Evoked Cough Responses: A Double-Blind Randomized Placebo Controlled 2-way Cross-Over Study","year":2022,"lang":"en","type":"article","venue":"05.01 - Airway pharmacology and treatment","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Salbutamol; Placebo; Bronchoconstriction; Medicine; Mannitol; Anesthesia; Bronchodilator; Asthma; Pharmacology; Airway; Internal medicine; Chemistry; Biochemistry","score_opus":0.029006524293964442,"score_gpt":0.3908387109654875,"score_spread":0.36183218667152306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313048206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805633,0.0024425585,0.0016872342,0.00030871696,0.00094662455,0.012529328,0.0007018838,0.00010806972,0.0007123561],"genre_scores_gemma":[0.95550805,0.0030407028,0.0073180436,0.0013856025,0.0017319536,0.025214592,0.0010364464,0.000056167766,0.004708414],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973725,0.0011913908,0.000301395,0.00046930893,0.00035826443,0.00030709687],"domain_scores_gemma":[0.9975435,0.00052829203,0.0004980874,0.000320903,0.00041538666,0.0006937173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050741048,0.0021715176,0.005627452,0.0009860571,0.0011574092,0.0012831441,0.0016029783,0.0032547985,0.0052036922],"category_scores_gemma":[0.0025951306,0.0014571513,0.0017494314,0.0006311111,0.0023805334,0.0012689197,0.00077370554,0.002068341,0.0010266531],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9184714,0.0519602,0.0005686687,0.0008119112,0.0005668013,0.00004018918,0.00009229386,0.000076996104,0.018667439,0.00005748337,0.00021344793,0.008473143],"study_design_scores_gemma":[0.56491154,0.42456114,0.0056480346,0.00004121715,0.0006245973,0.000029828447,0.000045189765,0.0002452627,0.002918727,0.00007782562,0.00086401653,0.00003257934],"about_ca_topic_score_codex":0.00087513914,"about_ca_topic_score_gemma":0.0011292449,"teacher_disagreement_score":0.005627452,"about_ca_system_score_codex":0.0005655823,"about_ca_system_score_gemma":0.001608464,"threshold_uncertainty_score":0.026834726},"labels":[],"label_agreement":null},{"id":"W4313170917","doi":"10.1183/13993003.congress-2022.3660","title":"Phosphoinositide-3 kinase antagonism does not reverse steroid insensitivity in severe asthma","year":2022,"lang":"en","type":"article","venue":"05.01 - Airway pharmacology and treatment","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dexamethasone; Apoptosis; LY294002; Eosinophil; Viability assay; Endocrinology; Annexin; Internal medicine; Antagonist; Pharmacology; PI3K/AKT/mTOR pathway; Chemistry; Medicine; Asthma; Receptor; Biochemistry","score_opus":0.013615669580336913,"score_gpt":0.2808234204423921,"score_spread":0.2672077508620552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313170917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98893154,0.008446691,0.00038899286,0.00027272297,0.00015342861,0.000068694644,0.0002568488,0.000084975145,0.0013961837],"genre_scores_gemma":[0.9940335,0.0029063073,0.00035284486,0.00018074272,0.00006569451,0.000037854235,0.00056828733,0.000008789182,0.0018460247],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99990726,0.000015483487,0.000010638166,0.00001297377,0.000025819267,0.00002775858],"domain_scores_gemma":[0.99986327,0.000023384095,0.000021189873,0.000016757007,0.00001187613,0.00006340871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013347255,0.00024992164,0.0006078578,0.00009338882,0.00012892521,0.00022685749,0.00022362756,0.00030915372,0.0030209708],"category_scores_gemma":[0.00017295785,0.00010260339,0.00029562914,0.00007007047,0.00017034716,0.00012730206,0.00016431481,0.0012508412,0.0006063161],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064365654,0.0010623945,0.0018527771,0.00034872346,0.00007540828,0.00047962627,0.00004457447,0.00012448148,0.95871955,0.00007071783,0.00069925917,0.030085871],"study_design_scores_gemma":[0.0034371857,0.071314886,0.14628728,0.00013620664,0.00037377907,0.0057551847,0.00030611557,0.002079543,0.7435227,0.00032136764,0.026432287,0.00003352169],"about_ca_topic_score_codex":0.0004130845,"about_ca_topic_score_gemma":0.00090845115,"teacher_disagreement_score":0.0030209708,"about_ca_system_score_codex":0.000105811894,"about_ca_system_score_gemma":0.00023889929,"threshold_uncertainty_score":0.010106146},"labels":[],"label_agreement":null}]}